[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_732 

# __Economic stability__

## Articles mentionning this Benefit

* [Health, Economic and Social Development Challenges of the COVID-19 Pandemic: Strategies for Multiple and Interconnected Issues](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_144.md)

## Category to which it belongs

* [Improved financial outcomes through financial relief, increased funding, sustainable and additional funding, private investment, and reduced financial losses.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_20.md)

## Description of actual returns pertaining to this benefit

* [Private investors benefit from a stable economic environment, which increases the value of their assets and investments.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_792.md)

## Name of the Benefit

Non-pharmaceutical interventions stabilize the economy by reducing the spread of the virus and allowing businesses to operate more normally.

## Risks which can benefit from this action

* [Implementation of non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_723.md)

## Stakeholders benefitting from this Benefit

* [Businesses](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_147.md)
* [Private investors](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_89.md)

